McKesson Corporation (MCK)

McKesson Corporation (MCK) is a healthcare company (medical distribution) based in the United States. The share price is $1,097.75, down 0.66% on the day, which values the company at $126.74B. Price as of 17 Nov 2026, 17:29 UTC, from Yahoo Finance.

Key facts

Share price
$1,097.75−0.66% today
Market value
$126.74B
P/E ratio
28.3×last 12 months
Forward P/E
21.0×
Dividend yield
0.31%
Funk Score
57/100
Against its own history
Well above its usual priceusual price $585.48
200-week average
$632.5674% above

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

McKesson Corporation in more detail

MCK trades at 28.3× its last twelve months' earnings, 21.0× next year's expected earnings, 0.3× sales. Measured against its own history, the price is 87% above what its usual multiples would imply ($585.48) — well above its usual price. It sits 74% above its 200-week average of $632.56.

Over the last five fiscal years McKesson Corporation has compounded revenue 11.1% a year, free cash flow 5.7% a year. Its Funk Score is 57 out of 100 (financial strength 7.8, profitability 5.2, growth 6.7, value 3.2, each out of 10).

In its favour: Altman Z in the safe zone; Share count keeps falling. Worth checking: Gross margin is shrinking.

13 of the superinvestors tracked here hold MCK, including Ron Muhlenkamp (founder) (5.7% of the portfolio), Charles Brandes (founder) (0.8% of the portfolio), Frank Sands (0.6% of the portfolio).

Superinvestors holding MCK

13 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:MCK vs SYK (McKesson Corporation vs Stryker)MCK vs BMY (McKesson Corporation vs Bristol-Myers Squibb)MCK vs SNY (McKesson Corporation vs Sanofi)MCK vs MDT (McKesson Corporation vs Medtronic)MCK vs MRNA (McKesson Corporation vs Moderna)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

McKesson Corporation (MCK): questions and answers

What is MCK's P/E ratio?

McKesson Corporation trades at 28.3× its last twelve months' earnings and 21.0× next year's expected earnings. At its fiscal year-ends over the past 17 years the P/E ranged from 6.5× to 440.2×, with a median of 19.3×.

What is MCK's PEG ratio?

McKesson Corporation's PEG ratio is 1.90 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is McKesson Corporation's market cap?

McKesson Corporation is valued at $126.74B at a share price of $1,097.75.

Is MCK overvalued or undervalued?

Against its own history, MCK is well above its usual price: the price is 87% above the $585.48 implied by the median multiples it has traded at (price / earnings, price / sales, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is MCK above its 200-week moving average?

Yes. MCK is 73.5% above its 200-week average of $632.56. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is McKesson Corporation growing?

Over the last five fiscal years McKesson Corporation's revenue grew 11.1% a year; over ten years revenue grew 7.8% a year.

Cite this page

Funkfolio, “McKesson Corporation (MCK) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/MCK

Underlying data: Yahoo Finance; company filings with the SEC.